- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
NuCana PLC (NCNA)
Assess today's live NuCana PLC (NCNA) share price, performance and insights using our live NASDAQ: NCNA stock exchange data.
Analyse the historical data and NuCana PLC share price performance charts on this page. Our technical summary section provides analysis on NuCana share price buy/sell indicators using real-time data (or discuss the NuCana (NCNA) stock price today with other investors in the NuCana NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ NCNA share price (ISIN: US67022C3043) to enhance your trading decisions with our free investment tools and resources.
What Is the NuCana PLC Share Price Today?
The NuCana share price today is 3.310.
What Is the Stock Symbol for NuCana PLC
The stock symbol (or 'ticker') for NuCana PLC is "NCNA."
What Stock Exchange Does NuCana PLC Trade On?
NuCana PLC is listed and trades on the NASDAQ stock exchange.
Is NuCana PLC a Good Stock to Buy?
Determining whether NuCana PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and NuCana PLC share price performance charts on this page. Our technical summary section provides analysis on NuCana share price buy/sell indicators using real-time data (or discuss the NuCana (NCNA) stock price today with other investors in the NuCana NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ NCNA share price (ISIN: US67022C3043) to enhance your trading decisions with our free investment tools and resources.
What Is the NuCana PLC Share Price Today?
The NuCana share price today is 3.310.
What Is the Stock Symbol for NuCana PLC
The stock symbol (or 'ticker') for NuCana PLC is "NCNA."
What Stock Exchange Does NuCana PLC Trade On?
NuCana PLC is listed and trades on the NASDAQ stock exchange.
Is NuCana PLC a Good Stock to Buy?
Determining whether NuCana PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.300
3.480
52 wk Range
2.780
330.000
NCNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.3003.480
52 wk Range
2.780330.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NCNA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 6K NuCana PLC For: 13 November
- Investing.com
- Form 6K NuCana PLC For: 13 November
- Investing.com
- Form 6K NuCana PLC For: 5 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
NuCana Company Profile
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer; Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer; and Phase 1 modular clinical trial for patients with advanced solid tumors and lung cancer. The company is also developing NUC-7738, a ProTide transformation of 3’-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is based in Edinburgh, the United Kingdom.
Compare NCNA to Peers and Sector
Metrics to compare | NCNA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNCNAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −6.1x | −0.6x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.4x | 0.8x | 2.6x | |
Price / LTM Sales | - | 133.6x | 3.2x | |
Upside (Analyst Target) | - | 76.5% | 41.8% | |
Fair Value Upside | Unlock | 2.1% | 5.1% | Unlock |
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.08 / -13.00
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the NuCana (NCNA) Share Price Today?
The live NuCana share price today is 3.310
What Stock Exchange Does NuCana (NCNA) Trade On?
NuCana is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for NuCana?
The stock symbol (also called a 'ticker') for NuCana is "NCNA."
What Is the Current NuCana Market Cap?
As of today, NuCana market capitalisation is 13.78M.
What Is NuCana's (NCNA) Earnings Per Share (TTM)?
The NuCana EPS is currently -22.80 (Trailing Twelve Months).
Is NCNA a Buy or Sell From a Technical Analyst Perspective?
Based on today's NuCana moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has NuCana Stock Split?
NuCana has split 2 times. (See the NCNA stock split history page for full effective split date and price information.)
How Many Employees Does NuCana Have?
NuCana has 21 employees.
What is the current trading status of NuCana (NCNA)?
As of 24 Dec 2025, NuCana (NCNA) is trading at a price of 3.310, with a previous close of 3.410. The stock has fluctuated within a day range of 3.300 to 3.480, while its 52-week range spans from 2.780 to 330.000.
What Is the NCNA Premarket Price?
NCNA's last pre-market stock price is 3.280. The pre-market share volume is 4,330.000, and the stock has decreased by -0.130, or -3.810%.
What Is the NCNA After Hours Price?
NCNA's last after hours stock price is 3.370, the stock has decreased by 0.060, or 1.810%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.